Cite
HARVARD Citation
Ahamadi, M. et al. (2017). Model‐Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti–PD‐1 Monoclonal Antibody in Advanced Solid Tumors. CPT: pharmacometrics & systems pharmacology. pp. 49-57. [Online].